Opt2mise 3


Safety

No severe hypoglycemia events with MiniMed insulin pump therapy and no increase in the time spent in hypoglycemia
No ketoacidosis events with MiniMed insulin pump therapy

Other results

-20% total daily insulin dose reduction with MiniMed insulin pump therapy when compared with MDI
+8% increase of HDL-cholesterol concentration with MiniMed insulin pump therapy and - 7% decrease in the MDI group
No significant difference in body weight change with MiniMed insulin pump therapy

*Results achieved do not guarantee results in all prospective new patients; variability as between patients is possible.